An aggressive lymphoma with a high mortality rate (Camicia et al. 2015), DLBCL is characterized by large lymphoid cells that carry B-cell surface antigens such as CD19 and CD20 (Jamil et al. 2021). The gene discussed is CD19; the disease is lymphoma.